申请人:KUME Masaharu
公开号:US20120123114A1
公开(公告)日:2012-05-17
A compound which inhibits both of EGF receptor tyrosine kinase and HER2 tyrosine kinase is provided.
A compound represented by the general formula (I):
wherein R
X
is a group represented by the formula:
wherein R
1
is a hydrogen atom, optionally substituted alkyl, etc.; Z is —O—, —N(R
10
)—, etc.; R
10
is a hydrogen atom, alkyl, etc.; R
2
is a hydrogen atom, optionally substituted alkyl, etc.; R
18
is a hydrogen atom, optionally substituted alkyl, etc.; R
19
is optionally substituted alkyl, etc.; W
1
is an optionally substituted non-aromatic nitrogen-containing group; R
17
is a hydrogen atom, optionally substituted alkyl, etc.; R
3
and R
4
are independently a hydrogen atom, optionally substituted alkyl, etc.; X is —O—, —S—, or —N(R
12
)—, etc.; R
12
is a hydrogen atom, alkyl, etc.; and A is phenyl optionally having a substituent, etc.,
its pharmaceutically acceptable salt, or a solvate thereof.
提供了一种同时抑制EGF受体酪氨酸激酶和HER2酪氨酸激酶的化合物。该化合物的普遍式表示为(I):其中,RX是由以下式表示的基团:其中,R1是氢原子,可选地取代的烷基等;Z为—O—,—N(R10)—等;R10为氢原子,烷基等;R2为氢原子,可选地取代的烷基等;R18为氢原子,可选地取代的烷基等;R19为可选地取代的烷基等;W1为可选地取代的非芳香族含氮基团;R17为氢原子,可选地取代的烷基等;R3和R4分别为氢原子,可选地取代的烷基等;X为—O—,—S—或—N(R12)—等;R12为氢原子,烷基等;A为苯基,可选地具有取代基等,其药学上可接受的盐或其溶剂化物。